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ABSTRACT
Common variable immunodefi ciency (CVID) or acquired hypogammaglobulinemia is the type of primary 
immunodefi ciency. Deregulation of the immune system, leading to hypogammaglobulinemia, defective 
activation and proliferation of T cells and dendritic cells, and malfunction of the cytokines are observed 
in CVID. The clinical picture of CVID varies, any organ or system can be affected, therefore the diagnosis 
is often diffi cult and delayed and sometimes is not always possible. This article describes a twelve years 
old boy with all the clinical signs of immunodefi ciency, as confi rmed by laboratory. The main treatment 
consists of life-long immunoglobulin substitution in intravenous or subcutaneous form.
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INTRODUCTION
Recurrent infections are the big challenge for both 
pediatricians and general practitioners. Recurrent 
pneumonia and bronchitis, prolonged, unrespon-
sive to standard treatment sinusitis or otitis should 
catch the doctor’s attention and prompt him to 
diff erential diagnosis towards primary immunode-
fi ciency disease (PIDD). Such disorders occur in 
clinical practice very rarely, but they shouldn’t be 
missed considering that early diagnosis provides 
rapid implementation of treatment and avoidance 
of complications. Common variable immunode-
fi ciency (CVID) or acquired hypogammaglobu-
linemia is the type of primary immunodefi ciency 
(1). Deregulation of the immune system, leading 
to hypogammaglobulinemia, defective activation 
and proliferation of T cells and dendritic cells, and 
malfunction of the cytokines are observed in CVID 
(2). Common variable immunodefi ciency frequency 
varies from 1 : 10 000 to 1 : 50 000, and the diagno-
sis is based on a reduced level of IgG and IgA and/or 
IgM, which is a consequence of impaired B cell de-
velopment (3). Th e disease manifests itself between 
5 and 10 years of age and between 20 and 40 years of 
age (4). Genetic basis of CVID is still unknown (1). 
Th e clinical picture of CVID varies, any organ or 
system can be aff ected, therefore the diagnosis is of-
ten diffi  cult and delayed. Th ere is, however,a broad 
spectrum of clinical manifestations including recur-
rent infections of the respiratory tract and chronic 
lung disease, various autoimmune pathology, gastro-
intestinal disease, granulomatous infi ltrative diseases, 
lymphoproliferative disorders and malignancies (5). 
It is estimated that about 78% of patients under-
went lower respiratory tract infection at least once 
before diagnosis of CVID (6). 
Recurrent infections, poorly responding to conven-
tional antibiotics, can lead to the formation of bron-
chiectasis, which are particularly common medical 
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problem, leading to frequent hospitalization and 
severe respiratory impairment. Early diagnosis usu-
ally protects the patient against this complication, 
however, development of bronchiectasis occurs even 
in 30% of patients, despite optimal treatment (7,8). 
About 20% of CVID patients developed diff erent 
gastrointestinal pathology, such as infl ammatory 
bowel disease, protein-loss enteropathy, spru-like 
syndrome, chronic enteritis caused by Giardia lam-
blia or Campylobacter infection, celiac sprue (9,10). 
Here, we report a case of 12 year boy with recurrent 
infections of the respiratory system who was diag-
nosed to have CVID. 
CASE REPORT
Th e patient is twelve years old boy who was admit-
ted to Department of Pediatric Allergy Immune 
Rheumatology with history of recurrent infections 
of the respiratory system, sinusitis, allergic rhinitis, 
allergies to nuts, conjunctivitis starting from the 
childhood. Bronchial asthma is diagnosed before 
three months. His medical history included severe 
swine fl u two years ago, tonsillectomy, appendec-
tomy, infl ammation of the nail bed of thumbs on 
both legs, severe form of varicella. Every two weeks 
he has oral ulcers. In his family history there is no 
evidence of hereditary immunodefi ciency or auto-
immune disease. Not regularly vaccinated. On ad-
mission the general physical examination revealed 
remarkable pallor, fever (40oC), cough, no enlarge-
ment of liver, spleen or peripheral lymph nodes. 
Routine laboratory parameters were found to be 
normal, except markers for infl ammation. Repeated 
hemocultures were negative. Microbiological analy-
sis excluded some viral infections (hepatitis B, C 
and HIV). Standard immunological markers (ANA, 
AMA, ANCA, ANTI ds DNA, and rheumatoid fac-
tor) were excluded for autoimmune and rheumatoid 
diseases. Screening tests of serum immunoglobulin's 
showed decreased concentrations of three types of 
immunoglobulin's: IgA: in traces, IgM 0.4 g/L and 
IgG 4.9 g/L. Lymphocyte immunophenotypisation 
revealed inversed CD4+/CD8+ T cells ratio: 0.96. 
Switched memory B cells were decreased. Chest X 
ray expressed bronchiectasis. 24 h pH monitoring 
indicate the presence of gastro esophageal refl ux 
disease (GERD). During the hospitalization the 
patient was treated with parenteral antibiotics. Re-
ceived replacement therapy with intravenous immu-
noglobulin at dosage 200mg/kg. 
DISCUSSION
CVID is essentially a diagnosis of exclusion, as 
other causes of hypogammaglobulinemia, including 
known gene defects, medications, protein loss, or 
malignancy, must be excluded (1). Correct diagno-
sis of immune defi ciency is not easy, and sometimes 
is not always possible (1,2). It often requires quite 
detailed studies that are not available in routine 
diagnostics. However, the initial suspicion of im-
munodefi ciency in a patient (Table 1) is possible at 
the level of every general practitioner (3). A careful 
investigation of past medical history is the fi rst step 
in the diagnosis. Past medical history should include 
the presence of allergic diseases. Also very important 
is the knowledge of the possible occurrence of im-
munodefi ciency in relatives. It should be established 
when the fi rst symptoms of immunodefi ciency such 
as persistent, recurrent infections occur. Children 
up to 6 month of age possess maternally derived 
antibodies, therefore, in accordance with European 
Society for the Immunodefi ciency's (ESID) criteria 
(Table 2) CVID can be recognized after 2 years of 
age (1,3). In addition to infections such as sinusitis, 
otitis media, bronchitis, pneumonia, or gastrointes-
tinal disorder, the nutritional status of the patient 
should be evaluated. Unexplained weight loss is 
relatively common symptom in CVID. Besides re-
current infections, CVID patients have an increased 
tendency to develop autoimmunity, lymph-prolifer-
ative disease and malignancies (2). Although these 
Eight or more infections per year
Two or more serious sinus infections within 1 year
Antibiotic therapy lasting two months or more without a clear 
improvement
Two or more pneumonias within 1 year
Growth and weight failure in infant
Recurrent deep skin or organ abscesses
Persistent thrush in mouth or fungal skin infection
Need for intravenous antibiotics to clear infections
Two or more deep-seated infections including: encephalitis, 
osteomyelitis, dermatitis, sepsis.
A family history of PID
TABLE 1.  Problems suggesting immune defi ciency disorders 
in children (for suspected immunodefi ciency just one of the 
following)
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disease complications cause severe morbidity, the 
enormous heterogeneity in the clinical presentation 
of CVID. Failure to make a diagnosis at the early 
stage can result in complications of recurrent infec-
tions particularly those of the chest (8). Th e clinical 
relevance of under diagnosing this disorder is that 
it precludes appropriate management by the use of 
intravenous immunoglobulin (IVIG). Th e primary 
treatment of CVID is replacement of antibody by 
either an intravenous or subcutaneous route, usu-
ally in doses of 400 to 600 mg/kg body weight per 
month (1). Our patient is receiving a lower dose 
because still produces some immunoglobulin's. Th is 
dose is usually divided into once or twice a week, or 
every 2 weeks (for the subcutaneous route) or every 
3 or 4 weeks (for the intravenous route). Although 
expensive, the use of IVIG can allow patients to lead 
a near normal life and perform productive work.
CONCLUSION 
Th is case highlights the importance of increasing 
awareness among primary care doctors for sus-
pecting and confi rming a diagnosis of CVID and 
to emphasize the need to perform basic laboratory 
tests and to determine immunoglobulin classes in 
clinical practice in patients with recurrent infections. 
Although IVIG provides improvement in these pa-
tients, early diagnosis is the key to preventing sig-
nifi cant morbidity and mortality and improving 
prognosis.
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Probable 
Male or female patient who has a marked decrease of IgG (at 
least 2 SD below the mean for age) and a marked decrease 
in at least one of the isotypes IgM or IgA, and fulfi lls all of the 
following criteria:
 1) Onset of immunodefi ciency at greater than 2 years of age
 2) Absent isohemagglutinins and/or poor response to vaccines
 3) Defi ned causes of hypogammaglobulinemia have been 
excluded
Posible 
Male or female patient who has a marked decrease (at least 2 
SD below the mean for age) in one of the major isotypes (IgM, 
IgG and IgA) and fulfi lls all of the following criteria:
 1) Onset of immunodefi ciency at greater than 2 years of age
 2) Absent isohemagglutinins and/or poor response to vaccines
 3) Defi ned causes of hypogammaglobulinemia have been 
excluded
TABLE 2.  European Society for the Immunodefi ciency's 
(ESID) Criteria for the diagnosis of CVID
